Showing results (1-10 of 2,990) with videos related to
Sort By:
Pageof 299
Lancet (London, England)|March 13, 2019
Heart failure drug treatmentPatrick Rossignol, Adrian F Hernandez, Scott D Solomon, et al.Expert Opinion on Pharmacotherapy|June 26, 2013
Loop diuretics and ultrafiltration in heart failurePatrick Rossignol, Faiez ZannadCurrent Opinion in Nephrology and Hypertension|November 21, 2012
Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseasesPatrick Rossignol, Michèle Kessler, Faiez ZannadKidney International|March 25, 2019
The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forwardPatrick Rossignol, Luc Frimat, Faiez ZannadHeart Failure Reviews|May 1, 2009
Extracellular matrix fibrotic markers in heart failureFaiez Zannad, Patrick Rossignol, Wafae IraqiInternational Journal of Cardiology|December 4, 2014
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registriesPatrick Rossignol, Faiez Zannad, Bertram Pitt, et al.Journal of the American College of Cardiology|October 23, 2012
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)Orly Vardeny, Dong Hong Wu, Akshay Desai, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 10, 2021
Weight changes in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Patrick Rossignol, Brian L Claggett, et al.Circulation. Heart Failure|May 10, 2014
Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonistOrly Vardeny, Brian Claggett, Inder Anand, et al.Pageof 299